Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients
Abstract Neoplasm development in Multiple Sclerosis (MS) patients treated with disease-modifying therapies (DMTs) has been widely discussed. The aim of this work is to determine neoplasm frequency, relationship with the prescription pattern of DMTs, and influence of the patients’ baseline characteri...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/9e0434f4136d47b6b5db10f717e47481 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|